Merck KGaA (XSWX:MER) Total Tax Payable: CHF1,444 Mil (As of Mar. 2026)


XSWX:MER Merck KGaA XSWX:MER
82 GF Score
Price CHF132.00
GF Value CHF128.27
! 9 Warning Signs
View Full Analysis

What is Merck KGaA Total Tax Payable?

Merck KGaA XSWX:MER 82 Total Tax Payable is CHF1,444 Mil as of Mar. 2026. GuruFocus rates XSWX:MER with a GF Score™ of 82/100 and a GF Value™ of CHF128.27. The stock has 9 warning signs investors should review.

Merck KGaA's Total Tax Payable for the quarter that ended in Mar. 2026 was CHF1,444 Mil.

Merck KGaA's quarterly Total Tax Payable increased from Sep. 2025 (CHF1,534 Mil) to Dec. 2025 (CHF1,597 Mil) but then declined from Dec. 2025 (CHF1,597 Mil) to Mar. 2026 (CHF1,444 Mil).

Merck KGaA's annual Total Tax Payable increased from Dec. 2023 (CHF1,505 Mil) to Dec. 2024 (CHF1,555 Mil) and increased from Dec. 2024 (CHF1,555 Mil) to Dec. 2025 (CHF1,597 Mil).

Merck KGaA Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Merck KGaA's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck KGaA Total Tax Payable Chart

Merck KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,714.00 1,660.89 1,505.15 1,555.40 1,596.60

Merck KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,534.12 1,492.27 1,534.27 1,596.60 1,443.54
XSWX:MER
82GF Score
Merck KGaA XSWX:MER
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck KGaA Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of CHF1,444 Mil mean?
Merck KGaA (XSWX:MER) has a Total Tax Payable of CHF1,444 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Merck KGaA and its competitors.
Is Merck KGaA's Total Tax Payable too high?
Merck KGaA's current Total Tax Payable is CHF1,444 Mil. Overall, Merck KGaA has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Total Tax Payable compare to ZTS and UTHR?
Merck KGaA's Total Tax Payable of CHF1,444 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Merck KGaA and its competitors. Merck KGaA's current Total Tax Payable is CHF1,444 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XSWX:MER) has a current Total Tax Payable of CHF1,444 Mil. The stock's GF Value™ is CHF128.27, compared to a current price of CHF132.00 — trading 2.9% above its estimated fair value. The current Total Tax Payable is CHF1,444 Mil. Merck KGaA's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current Total Tax Payable is CHF1,444 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck KGaA (XSWX:MER) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be overvalued. The current stock price of CHF132.00 is trading 2.9% above its estimated GF Value™ of CHF128.27.

Key valuation signals for XSWX:MER:

  • Total Tax Payable: CHF1,444 Mil
  • GF Value™: CHF128.27 vs. price of CHF132.00 (2.9% above fair value)
  • GF Score™: 82/100 with 9 warning signs

No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck KGaA Business Description

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
82GF Score

Get the complete analysis for XSWX:MER

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF132.00
Price
CHF128.27
GF Value